SAF-Holland SE : A trend reversal is in sight
Entry price | Target | Stop-loss | Potential |
---|
€13.39 |
€14.78 |
€12.51 |
+10.38% |
---|
The technical chart pattern of SAF-HOLLAND stock suggests the beginning of a trend reversal over the medium term.
Strengths● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.65 for the 2018 fiscal year.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 12.23 for the current year.
● The company is one of the best yield companies with high dividend expectations.
● Sales forecast by analysts have been recently revised upwards.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● For the last four months, EPS estimates made by Thomson-Reuters analysts have been revised downwards.
● Below the resistance at 15.95 EUR, the stock shows a negative configuration when looking looking at the weekly chart.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.